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Introduction {#sec001}
============

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of abnormal liver biochemistry worldwide. Its prevalence is increasing in Asia \[[@pone.0139310.ref001]--[@pone.0139310.ref003]\]. The worldwide prevalence of NAFLD in general population is estimated to be 20 to 30% in Western countries and 5 to 18% in Asia \[[@pone.0139310.ref003]\]. NAFLD may progress to a wide range of liver abnormalities, ranging from nonalcoholic steatohepatitis (NASH), cirrhosis, liver failure and liver cancer. It is also considered as the leading etiology for cryptogenic cirrhosis \[[@pone.0139310.ref004],[@pone.0139310.ref005]\]. Substantial evidence supports that NAFLD, obesity and metabolic syndrome are strongly correlated, and NAFLD is an independent cardiovascular risk factor \[[@pone.0139310.ref006],[@pone.0139310.ref007]\]. Therefore, determining risk factors for hepatic steatosis are important.

Diet may affect the development of NAFLD, and dietary alterations have been suggested as a cornerstone for the management of NAFLD \[[@pone.0139310.ref008]\]. However, epidemiological data on the association between diet or nutrient composition and the development of NAFLD are limited. Previous studies on this aspect were mainly conducted in Caucasian populations. Most previous studies were limited by small sample size \[[@pone.0139310.ref009],[@pone.0139310.ref010]\] and focused on high-risk population or NAFLD patients \[[@pone.0139310.ref011]--[@pone.0139310.ref014]\]. Only few studies have included participants from a representative general population \[[@pone.0139310.ref015]--[@pone.0139310.ref017]\]. Moreover, the examination of diet as a risk factor for NAFLD has traditionally focused on the effect of single foods and nutrients, such as soft drinks and meat \[[@pone.0139310.ref016]\], fructose \[[@pone.0139310.ref018]\], choline \[[@pone.0139310.ref019]\] and n-3 polyunsaturated fatty acids \[[@pone.0139310.ref017]\]. Recently, a possible link between dietary acid-base load and NAFLD has also been suggested \[[@pone.0139310.ref020],[@pone.0139310.ref021]\]. However, since diet is a combination of multiple exposures of food and nutrients, dietary pattern analysis is considered to be an alternative approach to investigate the association between diet and disease risk in epidemiological studies \[[@pone.0139310.ref022]\]. This approach involves the examination of the whole diet and considers the synergy of food and nutrient consumption, thus it may be more predictive of disease risk in comparison to individual foods or nutrients \[[@pone.0139310.ref022],[@pone.0139310.ref023]\].

To our knowledge, only few observational studies \[[@pone.0139310.ref024]--[@pone.0139310.ref029]\] have been conducted to examine the association between dietary patterns and NAFLD in adults and one prospective study has been done in a population-based cohort of adolescents \[[@pone.0139310.ref030]\]. In view of the scarcity of evidence on this topic and the fact that Chinese diets are different from Western diets, the present study aimed to examine the association of two diet-quality scores, namely the Mediterranean Diet Score (MDS) and the Diet Quality Index-International (DQI-I) with NAFLD prevalence in 797 Chinese aged 18 years or above, using data from a population-based study in Hong Kong. The MDS was selected because the Mediterranean diet has been widely reported for its many health benefits including its potential protective effect against NAFLD \[[@pone.0139310.ref031],[@pone.0139310.ref032]\]. The traditional Chinese diet also shares several similarities with the Mediterranean diet, such that the MDS can be applied to Chinese population \[[@pone.0139310.ref033]\]. The DQI-I was chosen as it provides an effective means of cross-national comparative work for global understanding of diet quality, and has been used in epidemiological studies to quantify the diet quality in Chinese population \[[@pone.0139310.ref034],[@pone.0139310.ref035]\]. We hypothesized that higher diet-quality score was associated with a reduced likelihood of NAFLD.

The present analysis was different from the findings regarding the possible link between dietary acid-base load and NAFLD of the same study population \[[@pone.0139310.ref020]\] in regard to the approach of analyzing dietary data. The present analysis used the dietary pattern approach in which the synergy of food and nutrient consumption was considered, while the previous analysis considered the association of a single nutritional factor, namely dietary acidity with the likelihood of NAFLD. Otherwise, both analyses followed the same study protocol ([S1](#pone.0139310.s001){ref-type="supplementary-material"} and [S2 Files](#pone.0139310.s002){ref-type="supplementary-material"}).

Materials and Methods {#sec002}
=====================

Study population {#sec003}
----------------

The study population were 797 subjects who aged 18 years or above and participated in a cross-sectional population screening study for NAFLD. Details of the screening project have been reported previously \[[@pone.0139310.ref036],[@pone.0139310.ref037]\] ([S1 File](#pone.0139310.s001){ref-type="supplementary-material"}) and can be found in the study protocol ([S2 File](#pone.0139310.s002){ref-type="supplementary-material"}). Those with active malignancy, metallic implants or other contraindications to magnetic resonance imaging, positive hepatitis B surface antigen or antibody against hepatitis C virus, treatment with steatogenic drugs (e.g. corticosteroids and estrogens), secondary causes of fatty liver (e.g. consumption of amiodarone and tamoxifen) and decompensated liver disease (defined as bilirubin above 50 μmol/l, albumin below 35 g/l, platelet count below 150 × 10^9^/l, international normalized ratio above 1.3, or the presence of ascites or varices) (n = 147) were excluded \[[@pone.0139310.ref036],[@pone.0139310.ref037]\]. The present study also excluded those with excessive alcohol use (defined as more than 20 g/d day in men and more than 10 g/d in women) (n = 30) and those with incomplete dietary data (n = 95) from the final analysis. The study protocol conformed to the ethical guidelines of the Declaration of Helsinki, and was approved by the Clinical Research Ethics Committee of The Chinese University of Hong Kong. All subjects provided informed written consent.

Clinical assessment {#sec004}
-------------------

At the baseline clinic visit, information of drug history, alcohol intake, smoking and past medical history were collected using a standardized questionnaire. Anthropometric measurements including body weight, body height, waist and hip circumferences were obtained using standardized methods. Blood tests for liver biochemistry, glucose and lipids were taken after at least 8 hours of fasting. Metabolic syndrome was defined according to the ethnic-specific criteria by the International Diabetes Federation, which was modified from the National Cholesterol Education Program, Adult Treatment Panel III Guidelines \[[@pone.0139310.ref038]\]. Details of the clinical assessment have been described previously \[[@pone.0139310.ref036]\].

Proton-magnetic resonance spectroscopy (^1^H-MRS) {#sec005}
-------------------------------------------------

^1^H-MRS was performed to measure intrahepatic triglyceride content (IHTG) within 8 weeks from the baseline visit. Details of the scanning sequence and analysis have been described previously \[[@pone.0139310.ref036],[@pone.0139310.ref039]\]. Whole-body 3.0T scanner with a single voxel point-resolved spectroscopy sequence and an echo time of 40 ms and repetition time of 5,000 ms was used. Fatty liver was defined as an IHTG of 5% or more \[[@pone.0139310.ref040]\].

Genetic analysis {#sec006}
----------------

Genomic DNA was extracted from 100 μl buffy coat using QIAamp Blood DNA Mini Kit (Qiagen, Germany) and QIAcube System (Qiagen, Germany). Extracted DNA was quantified using Nanodrop 1000 (Thermo Fisher Scientific, USA). For each subject, 20 ng of genomic DNA was used for *PNPLA3* rs738409 allelic discrimination using TaqMan® SNP Genotyping Assays (Life Technologies, USA) on the Applied Biosystems 7900HT Fast Real-Time PCR System (Life Technologies, USA). Details have been described elsewhere \[[@pone.0139310.ref041]\].

Dietary assessment {#sec007}
------------------

A locally validated food-frequency questionnaire (FFQ) was used to capture food intake and dietary intake over 7 days \[[@pone.0139310.ref042]\]. The questionnaire contained 297 food items in seven broad categories: bread / pasta / rice; vegetables; fruit; meat / fish / egg; beverages; dimsum / snacks; soups; and oil / salt / sauces. Subjects were asked to complete the questionnaires under the supervision of a trained research staff, with food models, food containers, and a catalogue of pictures of individual food portions provided to facilitate portion size estimation. The amount of cooking oil was calculated based on the usual cooking methods, the usual type of cooking oil and the usual portion of different foods used by the subjects \[[@pone.0139310.ref043]\]. Daily nutrient intakes and food group intakes were estimated using Food Processor Nutrition analysis and Fitness software version 8.0 (ESHA Research, Salem, Oregon, USA) with the addition of local and Chinese food items \[[@pone.0139310.ref044]--[@pone.0139310.ref046]\]. All nutrient intakes were energy adjusted by the residual method for regression analysis \[[@pone.0139310.ref047]\]. Details of the dietary assessment have been described previously \[[@pone.0139310.ref020]\].

The Mediterranean Diet Score (MDS) {#sec008}
----------------------------------

Adherence to the Mediterranean diet was calculated using the revised method described by Trichopoulou *et al*. \[[@pone.0139310.ref048]\]. One score was assigned to consumption of the food groups considered beneficial to health at or above the sex-specific median (vegetables, legumes, fruits and nuts, cereal, fish and monosaturated to saturated lipids ratio). Similarly, one score was also assigned to consumption of the food groups presumed to be detrimental to health (meat, poultry and dairy products) below the median. Because a substantial proportion of subjects did not consume alcohol, the component of ethanol consumption was excluded in the scoring. Therefore, total MDS ranged from 0 (minimal adherence) to 8 (maximal adherence) instead of 0 to 9.

Dietary Quality Index-International (DQI-I) {#sec009}
-------------------------------------------

The Dietary Quality index-International (DQI-I) was calculated according to the method described by Kim *et al*. \[[@pone.0139310.ref034]\]. Four major aspects of the diet are assessed in the DQI-I, namely variety, adequacy, moderation and overall balance. The score ranges from 0 to 100 and higher score represents better diet quality. In this study, we did not have enough information to calculate the category of empty-calorie foods under the aspect 'moderation'. Therefore the range of score for moderation was 0 to 24 instead of 0 to 30 as originally proposed in the calculation, and the DQI-I total score was 0 to 94 instead of 0 to 100. Details of the DQI-I calculation have been described elsewhere \[[@pone.0139310.ref049]\].

Statistical analysis {#sec010}
--------------------

Statistical tests were performed using the Statistical Package for Social Sciences version 21.0 (SPSS Inc., Chicago, US). Histograms were used to screen for normal distribution. Logarithmic transformation was applied to skewed variables whenever appropriate. Continuous variables were expressed in mean ± SD and compared using the independent *t* test if they were normally distributed. Skewed variables were expressed in median (IQR) and compared using the Mann-Whitney U test. Categorical variables were compared using chi-squared test or Fisher exact test as appropriate. Hardy--Weinberg equilibrium of alleles was assessed by chi-squared test. Pearson's correlation or Spearman's rank correlation was used to examine the correlation between each diet-quality score and food group or nutrient intakes whenever appropriate.

The association between each diet-quality score and IHTG and the presence of NAFLD was analyzed using multivariate linear regression and logistic regression models, respectively. The first model was adjusted for sex and age (continuous). The second model was further adjusted for BMI (continuous), daily energy intake (continuous), current smoker status (yes/no), current drinker status (yes/no), the five individual metabolic components including central obesity (yes/no), triglyceride \>1.7 mmol/l (yes/no), reduced HDLC (yes/no), hypertension (yes/no), and impaired fasting glucose or diabetes (yes/no), and the *PNPLA3* genotypes. We also examined whether the association between each diet-quality score and the presence of NAFLD varied according to sex, BMI, age, current drinker status, the presence of metabolic syndrome, or the *PNPLA3* genotypes. All models were additionally stratified by sex (men and women), age (\<50 vs. \> = 50 years), BMI (normal weight group \<23 vs. overweight and obese group \> = 23 kg/m^2^), current drinker status (yes vs. no), the presence of metabolic syndrome (yes vs. no), and the *PNPLA3* genotypes (CC vs. CG vs. GG genotypes). We also investigated potential effect modifications by sex, age, BMI, current drinker status, the presence of metabolic syndrome and the *PNPLA3* genotypes by inclusion of cross-product terms to the regression models. No significant interactions were detected for all these stratified variables, thus data were presented based on the results of the whole sample. The above multivariate logistic regression models were repeated to explore the association between each energy adjusted nutrient intake variable or food group intake variable and the prevalence of NAFLD. Due to the skewness in the distribution for most food group intake variables, the food group intake variables were categorized into tertiles based on the distribution of the entire sample. Odds ratios (OR) were computed to compare the middle and upper tertile groups with the lower tertile group. Test for trend was examined by entering tertiles of food group intake as a fixed factor and testing the contrast by using the polynomial option in all models. All tests were 2-sided and *P* values less than 0.05 were considered statistically significant.

Results {#sec011}
=======

There was no major difference in the baseline characteristics between the included subjects and the excluded subjects (data not shown). The mean ± SD age of 797 subjects was 48.1 ± 10.6 years (range 19--72 years), and 332 (41.7%) were male. All subjects were ethnic Chinese. Two hundred and twenty subjects were diagnosed with NAFLD and the prevalence of NAFLD was 27.6%. Subjects with NAFLD were older, and were likely to be male and current drinkers than subjects without NAFLD (all *p*\<0.05). They also had significantly higher BMI and higher WC than those without NAFLD. The metabolic profiles differed significantly between the two groups. Subjects with NAFLD showed lower age and sex adjusted MDS and DQI-I than subjects without NAFLD ([Table 1](#pone.0139310.t001){ref-type="table"}). There were 311 (39.0%) CC homozygotes, 380 (47.7%) CG heterozygotes and 105 (13.2%) GG homozygotes. The alleles of *PNPLA3* rs738409 polymorphism of the total study sample or of the stratified sample by NAFLD status were in Hardy-Weinberg equilibrium (*p* = 0.511 for total sample, *p* = 0.533 for non-NAFLD group, *p* = 0.414 for NAFLD group).

10.1371/journal.pone.0139310.t001

###### Baseline subject characteristics between subjects with and without NAFLD (n = 797).

![](pone.0139310.t001){#pone.0139310.t001g}

                                                                                   No NAFLD (n = 577)                                  NAFLD (n = 220)   *P* [^1^](#t001fn001){ref-type="table-fn"}      Age and sex adjusted *P* [^2^](#t001fn002){ref-type="table-fn"}
  -------------------------------------------------------------------------------- --------------------------------------------------- ----------------- ----------------------------------------------- -----------------------------------------------------------------
  Age (years)                                                                      47.0 ± 10.8[^3^](#t001fn003){ref-type="table-fn"}   51.0 + 9.3        \<0.001                                         ----
  BMI (kg/m^2^)                                                                    21.7 ± 3.0                                          25.5 + 3.5        \<0.001                                         \<0.001
  WC (cm)                                                                          78.4 ± 9.2                                          89.2 + 7.6        \<0.001                                         \<0.001
  Male \[n (%)\]                                                                   214 (37.1)                                          118 (53.6)        \<0.001                                         ----
  Current smoker \[n (%)\]                                                         48 (8.3)                                            19 (8.6)          0.885                                           0.504
  Current drinker \[n (%)\]                                                        96 (16.6)                                           55 (25.0)         0.007                                           0.177
  MDS                                                                              4.0 ± 1.7[^3^](#t001fn003){ref-type="table-fn"}     4.0 + 1.8         0.904                                           0.068
  DQI-I                                                                            57.9 ± 10.4                                         57.2 + 11.5       0.368                                           0.007
  SBP (mmHg)                                                                       126.1 ± 19.0                                        137.8 + 19.0      \<0.001                                         \<0.001
  DBP (mmHg)                                                                       79.2 ± 11.3                                         88.3 + 12.6       \<0.001                                         \<0.001
  Alanine aminotransferase (IU/l)                                                  19 (15--25)                                         31 (23--42)       \<0.001[^4^](#t001fn004){ref-type="table-fn"}   \<0.001
  Fasting glucose (mmol/l)                                                         4.9 (4.6--5.2)                                      5.2 (4.9--5.6)    \<0.001[^4^](#t001fn004){ref-type="table-fn"}   \<0.001
  Total cholesterol (mmol/l)                                                       5.1 + 1.0                                           5.4 + 1.0         \<0.001                                         0.012
  HDL-cholesterol (mmol/l)                                                         1.6 + 0.4                                           1.3 + 0.3         \<0.001                                         \<0.001
  Triglycerides (mmol/l)                                                           0.9 (0.7--1.2)                                      1.6 (1.2--2.3)    \<0.001[^4^](#t001fn004){ref-type="table-fn"}   \<0.001
  LDL-cholesterol (mmol/l)                                                         2.9 ± 0.8                                           3.2 + 0.9         \<0.001                                         0.002
  Central obesity[^5^](#t001fn005){ref-type="table-fn"} \[n (%)\]                  160 (27.7)                                          143 (65.0)        \<0.001                                         \<0.001
  Triglycerides \> 1.7 mmol/l[^5^](#t001fn005){ref-type="table-fn"} \[n (%)\]      63 (10.9)                                           97 (44.1)         \<0.001                                         \<0.001
  Reduced HDL-cholesterol[^5^](#t001fn005){ref-type="table-fn"} \[n (%)\]          45 (7.8)                                            64 (29.1)         \<0.001                                         \<0.001
  Hypertension[^5^](#t001fn005){ref-type="table-fn"} \[n (%)\]                     251 (43.5)                                          161 (73.2)        \<0.001                                         \<0.001
  Impaired fasting glucose or DM[^5^](#t001fn005){ref-type="table-fn"} \[n (%)\]   53 (9.2)                                            61 (27.7)         \<0.001                                         \<0.001
  Metabolic syndrome[^5^](#t001fn005){ref-type="table-fn"} \[n (%)\]               45 (7.8)                                            105 (47.7)        \<0.001                                         \<0.001
  *PNPLA3* genotypes \[n (%)\]                                                                                                                                                                           
   CC                                                                              248 (43.1)                                          63 (28.6)         \<0.001                                         \<0.001
   CG                                                                              265 (46.0)                                          115 (52.3)                                                        
   GG                                                                              63 (10.9)                                           42 (19.1)                                                         
  Intrahepatic triglyceride content (%)                                            1.2 (0.7--2.4)                                      9.8 (7.0--15.4)   \<0.001[^4^](#t001fn004){ref-type="table-fn"}   \<0.001

^1^ Group difference by independent *t* test for continuous variables and chi-squared or Fisher exact test for categorical variables unless otherwise stated

^2^ Group difference by ANCOVA for continuous variables and logistic regression for categorical variables unless otherwise stated

^3^ Mean ± SD or median (interquarter range) (all such values) unless otherwise stated

^4^ Group difference by nonparametric Mann-Whiney U test

^5^ International Diabetes Federation criteria for metabolic syndrome \[[@pone.0139310.ref038]\]

BMI, body mass index; DBP, diastolic blood pressure; DM, diabetes mellitus; DQI-I, Diet Quality Index-International; MDS, Mediterranean Diet Score; NAFLD, nonalcoholic fatty liver disease; SBP, systolic blood pressure; WC, waist circumference

Higher MDS and DQI-I was associated with lower intakes of beverages, dim sum, egg and egg products, fast food, meat, poultry and organ meat. Both scores were positively associated with the intakes of fish and seafood, grains and cereals, and plant-based foods, such as fruits, soy and soy products, and vegetables and legumes ([Table 2](#pone.0139310.t002){ref-type="table"}). MDS and DQI-I were positively associated with percentage of energy from carbohydrate and intakes of dietary fiber and vitamin C, and negatively associated with percentage of energy from total fat and saturated fat, and cholesterol intake (all *p*\<0.05, [Table 2](#pone.0139310.t002){ref-type="table"}).

10.1371/journal.pone.0139310.t002

###### Correlation between each diet-quality score and selected food group and nutrient intakes (n = 797).

![](pone.0139310.t002){#pone.0139310.t002g}

  Daily food group/nutrient intake[^1^](#t002fn001){ref-type="table-fn"}   MDS      *P* value   DQI-I    *P* value
  ------------------------------------------------------------------------ -------- ----------- -------- -----------
  Beverages (ml)[^2^](#t002fn002){ref-type="table-fn"}                     -0.157   \<0.001     -0.198   \<0.001
  Dim sum (g)                                                              -0.015   0.671       -0.033   0.353
  Eggs (g)                                                                 -0.097   0.006       -0.207   \<0.001
  Fast food (g)                                                            -0.219   \<0.001     -0.185   \<0.001
  Meat, poultry and organ meats (g)                                        -0.242   \<0.001     -0.281   \<0.001
  Fish and seafood (g)                                                     0.394    \<0.001     0.151    \<0.001
  Fruits (g)                                                               0.508    \<0.001     0.604    \<0.001
  Grains and cereals (g)                                                   0.344    \<0.001     0.379    \<0.001
  Mushroom, fungi and nuts (g)                                             0.231    \<0.001     0.177    \<0.001
  Soy and soy products (g)                                                 0.350    \<0.001     0.235    \<0.001
  Vegetables and legumes (g)                                               0.512    \<0.001     0.539    \<0.001
  Milk and milk products (g)                                               -0.301   \<0.001     0.009    0.800
  Tea and coffee (ml)                                                      0.030    0.397       -0.016   0.642
  \% energy from carbohydrate                                              0.321    \<0.001     0.651    \<0.001
  \% energy from protein                                                   0.024    0.505       -0.022   0.539
  \% energy from total fat                                                 -0.311   \<0.001     -0.664   \<0.001
  \% energy from saturated fat                                             -0.473   \<0.001     -0.634   \<0.001
  Cholesterol (mg)                                                         -0.045   0.201       -0.220   \<0.001
  Dietary fiber (g)                                                        0.544    \<0.001     0.642    \<0.001
  Vitamin C (mg)                                                           0.502    \<0.001     0.615    \<0.001

^1^ Spearman's rank correlation was used for food group intake analysis and vitamin C intake analysis whereas Pearson's correlation was used for other nutrient intakes analysis

^2^ Included mainly sweetened beverages or juice, carbonated drinks and sports drinks

DQI-I, Diet Quality Index-International; MDS, Mediterranean Diet Score

The multivariate linear regression models suggested that a higher MDS or DQI-I was associated with a lower IHTG ([Table 3](#pone.0139310.t003){ref-type="table"}). Using an IHTG of 5% or more as a cut-off value to define NAFLD, the DQI-I was associated with the prevalence of NAFLD ([Table 4](#pone.0139310.t004){ref-type="table"}). A 10-unit decrease in DQI-I was associated with 24% increase in the likelihood of having NAFLD in the age and sex adjusted model (95% CI: 1.06--1.45, *p* = 0.009), and the association remained significant when the model was further adjusted for other lifestyle factors, metabolic components and the *PNPLA3* genotypes \[OR: 1.26 (95% CI: 1.03--1.54), *p* = 0.027\]. The multivariate adjusted association of DQI-I and the prevalence of NAFLD was stronger in male than in female, and in overweight or obese subjects than in normal weight subjects. Similar results were observed between the MDS and the prevalence of NAFLD, although the strength of the associations were not significant in comparison to those of the DQI-I with the NAFLD prevalence ([Table 4](#pone.0139310.t004){ref-type="table"}). Since significant correlations were observed between both diet-quality scores and most food groups or nutrients, the association of each major food group or nutrient with the likelihood of having NAFLD was further examined as to get a more concrete picture of the optimal diet in reducing NAFLD. Among all selected food groups and nutrients examined in the multivariate adjusted models, higher intake of vegetables and legumes, fruits and dried fruits, as well as vitamin C was consistently associated with reduced likelihood of having NAFLD ([Table 5](#pone.0139310.t005){ref-type="table"}).

10.1371/journal.pone.0139310.t003

###### Linear regression analysis linking each diet-quality score and the intrahepatic triglyceride content[^1^](#t003fn001){ref-type="table-fn"} (n = 797).
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  Diet-quality score   Age and sex adjusted   Multivariate adjusted[^2^](#t003fn002){ref-type="table-fn"}                            
  -------------------- ---------------------- ------------------------------------------------------------- ------- -------- ------- ---------
  MDS                  -0.036                 0.011                                                         0.001   -0.033   0.009   \<0.001
  DQI-I                -0.006                 0.002                                                         0.001   -0.004   0.001   0.003

^1^ Logarithmic transformation was applied for regression analysis

^2^ Further adjusted for BMI, energy intake, current smoker status (yes/no), current drinker status (yes/no), central obesity (yes/no), triglyceride \>1.7 mmol/l (yes/no), reduced HDL-cholesterol (yes/no), hypertension (yes/no), impaired fasting glucose or diabetes (yes/no), and the *PNPLA3* genotypes (CC vs. CG vs. GG genotypes)

DQI-I, Diet Quality Index-International; MDS, Mediterranean Diet Score

10.1371/journal.pone.0139310.t004

###### Overall and stratified logistic regression analysis linking each diet-quality score and the presence of NAFLD (n = 797).

![](pone.0139310.t004){#pone.0139310.t004g}

                        No. of    MDS (per 1 unit decrease)   DQI-I (per 10 unit decrease)                                                                                                   
  --------------------- --------- --------------------------- ------------------------------ ----------- ------ ------------ ----------- ------ ------------ ----------- ------ ------------ -----------
  Overall analysis      220/577   1.10                        0.99--1.21                     0.073       1.11   0.98--1.26   0.092       1.24   1.06--1.45   **0.009**   1.26   1.03--1.54   **0.027**
  Stratified analysis                                                                                                                                                                        
  Sex                                                                                                                                                                                        
      Male              118/214   1.09                        0.95--1.25                     0.244       1.17   0.98--1.38   0.081       1.30   1.06--1.61   **0.014**   1.34   1.03--1.75   **0.030**
      Female            102/363   1.12                        0.97--1.29                     0.111       1.01   0.85--1.21   0.901       1.20   0.95--1.52   0.134       1.09   0.80--1.47   0.588
  Age                                                                                                                                                                                        
      \<50 years        92/317    1.07                        0.92--1.24                     0.401       1.10   0.90--1.33   0.363       1.22   0.97--1.55   0.091       1.23   0.90--1.68   0.202
      \> = 50 years     128/260   1.04                        0.92--1.18                     0.497       1.05   0.90--1.23   0.525       1.15   0.94--1.41   0.188       1.11   0.86--1.44   0.410
  BMI status                                                                                                                                                                                 
      \<23 kg/m^2^      53/426    1.00                        0.83--1.21                     0.975       1.01   0.81--1.28   0.903       1.05   0.79--1.39   0.739       0.88   0.62--1.25   0.480
      \> = 23 kg/m^2^   167/147   1.16                        1.01--1.33                     **0.031**   1.19   1.03--1.38   **0.021**   1.29   1.04--1.61   **0.022**   1.39   1.09--1.77   **0.008**
  Current drinker                                                                                                                                                                            
      Yes               55/96     1.20                        0.97--1.48                     0.089       1.28   0.97--1.69   0.086       1.14   0.84--1.56   0.394       1.31   0.85--2.03   0.219
      No                165/481   1.06                        0.95--1.19                     0.313       1.05   0.91--1.20   0.511       1.25   1.04--1.51   **0.017**   1.17   0.93--1.47   0.174
  Metabolic syndrome                                                                                                                                                                         
      Yes               105/45    1.09                        0.88--1.34                     0.437       1.12   0.88--1.42   0.351       1.11   0.81--1.53   0.524       1.22   0.84--1.78   0.288
      No                115/532   1.06                        0.94--1.21                     0.345       1.06   0.91--1.22   0.467       1.22   0.99--1.50   0.059       1.20   0.94--1.53   0.142
  *PNPLA3* genotypes                                                                                                                                                                         
      CC                63/248    1.23                        1.02--1.49                     **0.029**   1.17   0.93--1.47   0.192       1.31   0.98--1.76   0.073       1.30   0.90--1.88   0.156
      CG                115/265   1.06                        0.92--1.22                     0.445       1.07   0.89--1.28   0.469       1.27   1.02--1.59   0.031       1.22   0.92--1.62   0.176
      GG                42/63     1.08                        0.87--1.34                     0.479       1.16   0.86--1.57   0.330       1.15   0.78--1.68   0.482       1.16   0.67--2.02   0.600

^1^ Adjusted for age and sex, expect for the stratified variable whenever appropriate.

^2^ Further adjusted for BMI, energy intake, current smoker status (yes/no), current drinker status (yes/no), central obesity (yes/no), triglyceride \>1.7 mmol/l (yes/no), reduced HDL-cholesterol (yes/no), hypertension (yes/no), impaired fasting glucose or diabetes (yes/no), and the *PNPLA3* genotypes (CC vs. CG vs. GG genotypes), except for the stratified variable whenever appropriate.

DQI-I, Diet Quality Index-International; MDS, Mediterranean Diet Score; NAFLD, non-alcoholic fatty liver disease

10.1371/journal.pone.0139310.t005

###### Logistic regression analysis linking individual food groups or nutrients and the presence of NAFLD (n = 797).

![](pone.0139310.t005){#pone.0139310.t005g}

  Food group/nutrient                                    Tertile[^1^](#t005fn001){ref-type="table-fn"}   No. of    Age and sex adjusted   Multivariate adjusted[^2^](#t005fn002){ref-type="table-fn"}                                   
  ------------------------------------------------------ ----------------------------------------------- --------- ---------------------- ------------------------------------------------------------- ----------- ------ ------------ -----------
  Beverages (ml)[^4^](#t005fn004){ref-type="table-fn"}   0                                               231/87    1                                                                                    **0.008**   1                   0.091
                                                         1--71                                           163/47    1.01                   0.66--1.54                                                                1.22   0.72--2.08   
                                                         71+                                             183/86    1.68                   1.14--2.47                                                                1.53   0.93--2.52   
  Dim sum (g)                                            \<14                                            202/76    1                                                                                    0.551       1                   0.548
                                                         14--40                                          188/67    1.07                   0.72--1.59                                                                1.06   0.64--1.75   
                                                         40+                                             187/77    1.13                   0.76--1.65                                                                1.16   0.71--1.89   
  Egg and egg products (g)                               \<7                                             209/79    1                                                                                    0.754       1                   0.471
                                                         7--21                                           150/57    1.00                   0.66--1.51                                                                0.81   0.48--1.34   
                                                         21+                                             218/84    1.06                   0.73--1.54                                                                0.84   0.52--1.36   
  Fast food (g)                                          0                                               343/135   1                                                                                    0.387       1                   0.588
                                                         1+                                              234/85    1.16                   0.83--1.63                                                                1.13   0.74--1.72   
  Meat, poultry and organ meats (g)                      \<91                                            197/68    1                                                                                    0.107       1                   0.368
                                                         91--150                                         199/68    1.05                   0.70--1.58                                                                1.30   0.78--2.17   
                                                         150+                                            181/84    1.39                   0.93--2.09                                                                1.30   0.73--2.32   
  Fish and seafood (g)                                   \<43                                            189/76    1                                                                                    0.911       1                   0.991
                                                         43--85                                          205/62    0.78                   0.52--1.16                                                                0.88   0.53--1.46   
                                                         85+                                             183/82    1.02                   0.70--1.50                                                                1.00   0.61--1.64   
  Fruits and dried fruits (g)                            \<132                                           185/80    1                                                                                    **0.007**   1                   **0.009**
                                                         132--229                                        195/71    0.73                   0.50--1.09                                                                0.70   0.43--1.16   
                                                         229+                                            197/69    0.57                   0.38--0.86                                                                0.50   0.30--0.84   
  Grains and cereals (g)                                 \<444                                           194/72    1                                                                                    0.173       1                   0.134
                                                         444--637                                        196/69    0.80                   0.53--1.19                                                                0.85   0.50--1.42   
                                                         637+                                            187/79    0.75                   0.49--1.14                                                                0.64   0.36--1.15   
  Mushroom, fungi and nuts (g)                           \<2                                             183/84    1                                                                                    **0.037**   1                   0.168
                                                         2--13                                           189/71    0.79                   0.54--1.16                                                                0.83   0.50--1.36   
                                                         13+                                             205/65    0.66                   0.44--0.98                                                                0.70   0.42--1.16   
  Soy and soy products (g)                               \<12                                            193/73    1                                                                                    0.731       1                   0.550
                                                         12--54                                          188/77    1.05                   0.71--1.55                                                                1.15   0.70--1.89   
                                                         54+                                             196/70    0.93                   0.63--1.38                                                                0.86   0.52--1.42   
  Vegetables and legumes (g)                             \<119                                           185/80    1                                                                                    **0.009**   1                   **0.013**
                                                         119--207                                        190/76    0.86                   0.58--1.27                                                                0.79   0.48--1.29   
                                                         207+                                            202/64    0.58                   0.38--0.87                                                                0.51   0.30--0.87   
  Milk and milk products (g)                             \<4                                             179/80    1                                                                                    0.054       1                   0.624
                                                         4--30                                           193/83    1.08                   0.74--1.58                                                                1.53   0.94--2.49   
                                                         30+                                             205/57    0.67                   0.45--1.01                                                                1.14   0.68--1.91   
  Tea and coffee (ml)                                    \<179                                           194/64    1                                                                                    0.166       1                   0.671
                                                         179--464                                        209/65    0.83                   0.55--1.24                                                                0.58   0.34--0.97   
                                                         464+                                            174/91    1.32                   0.89--1.96                                                                1.12   0.68--1.84   
  \% energy from carbohydrate                            ----                                            ----      0.98                   0.96--1.00                                                    **0.013**   0.98   0.95--1.00   0.067
  \% energy from protein                                 ----                                            ----      1.03                   0.98--1.08                                                    0.211       1.00   0.95--1.06   0.921
  \% energy from total fat                               ----                                            ----      1.02                   1.00--1.04                                                    0.130       1.03   1.00--1.06   0.089
  \% energy from saturated fat                           ----                                            ----      1.03                   0.95--1.13                                                    0.436       1.02   0.92--1.14   0.714
  Cholesterol (mg)                                       ----                                            ----      1.00                   0.99--1.00                                                    0.275       1.00   0.99--1.00   0.963
  Dietary fiber (g)                                      ----                                            ----      0.97                   0.94--1.00                                                    **0.036**   0.96   0.93--1.00   0.054
  Vitamin C (mg)                                         ----                                            ----      0.40                   0.19--0.85                                                    **0.017**   0.36   0.14--0.89   **0.028**

^1^ Tertiles based on the distribution of all subjects, except two categories for the fast food intake (intake = 0 vs. intake \> 0 g per day)

^2^ Further adjusted for BMI, current smoker status (yes/no), current drinker status (yes/no), central obesity (yes/no), triglyceride \>1.7 mmol/l (yes/no), reduced HDL-cholesterol (yes/no), hypertension (yes/no), impaired fasting glucose or diabetes (yes/no), and the *PNPLA3* genotypes (CC vs. CG vs. GG genotypes). Energy intake was further adjusted in the multivariate model of food group intake analysis.

^3^ *P* ~*trend*~ was examined by entering tertiles of food group intake as a fixed factor for the models of food group intake analysis, whereas *P* value was used for the models of nutrient intake analysis.

^4^ Included mainly sweetened beverages or juice, carbonated drinks and sports drinks

NAFLD, non-alcoholic fatty liver disease

Discussion {#sec012}
==========

In this cross-sectional, population based study, lower DQI-I was associated with increased likelihood of having NAFLD in Hong Kong Chinese adults. The association was stronger in male participants compared to female participants, and in individuals who were overweight or obese compared to those were normal weight. Our study also suggested that a higher intake of vegetables and legumes, fruits and dried fruits, as well as vitamin C was associated with a reduced likelihood of having NAFLD.

To our knowledge, only few observational studies \[[@pone.0139310.ref024]--[@pone.0139310.ref029]\] have been conducted to examine the association between dietary patterns and NAFLD in adults and one prospective study has been done in a population-based cohort of adolescents \[[@pone.0139310.ref030]\]. While Hasehemi kani *et al*. reported that higher scores in four different diet-quality indices might protect against NAFLD in a group of Iranian adults attending a gastrointestinal research clinic \[[@pone.0139310.ref024]\], Kongtogianni *et al*. found that greater adherence to the Mediterranean diet as measured using the MDS was associated with less severity of fatty liver disease but was not associated with the likelihood of having NAFLD \[[@pone.0139310.ref025]\]. A recent cross-sectional, population based study, however, showed that a dietary pattern, characterized by increased intake of alcohol and meat (poultry), and reduced consumption of tea, was associated with higher liver fat content in adults \[[@pone.0139310.ref029]\]. Only one observational study has previously investigated exploratory dietary patterns and NAFLD risk, which was limited to adolescents \[[@pone.0139310.ref030]\]. A Western dietary pattern characterized by a high intake of takeaway foods, confectionary, red meat, refined grains, processed meats, chips, sauces, full-fat dairy products, and soft drinks at 14 years of age was prospectively associated with NAFLD at 17 years. Different study design, choices and assessment methods of outcome measures, covariates and confounding factors included in the statistical analysis, as well as methods to generate dietary quality indices or dietary pattern scores in various studies might lead to the mixed findings.

Previous studies have related DQI-I or MDS with cardiovascular risk, obesity and metabolic outcomes, and generally support that better diet quality is associated with better cardiovascular or metabolic outcomes \[[@pone.0139310.ref050],[@pone.0139310.ref051]\]. To our knowledge, our study is the first study to report a positive association between DQI-I and NAFLD prevalence. Our findings also suggested that subjects consuming vegetables and legumes, as well as fruits and dried fruits of approximately ≥ 200 g/day each were likely to have 50% reduction in the likelihood of having NAFLD in comparison to subjects in the lowest tertile of consumption of these food groups. These intake levels are in line with the recommended intake of at least 400 g/day of vegetables and fruits by the World Health Organization for the prevention of diet-related chronic diseases \[[@pone.0139310.ref052]\]. Contrary to our findings that no association was observed between MDS and NAFLD prevalence, several observational studies and clinical trials have preliminarily suggested that higher adherence to the Mediterranean diet might protect against NAFLD \[[@pone.0139310.ref031],[@pone.0139310.ref032]\]. Although the Chinese diet has many similar features with the Mediterranean diet, in that vegetable and fruit consumption is high, and fat and meat consumption is low, the consumption of legumes, milk and milk products, nuts, olive oil and wine was less in our cohort than the traditional Mediterranean diet. These differences may be one of the reasons to explain the absence of association between MDS and NAFLD prevalence. Moreover, the various scores differ in many aspects of both indices, such as the items included, the cut-off values used, and the exact method of scoring may be some reasons to explain the different results of DQI-I and MDS in the present study. For example, the scores of various components of the DQI-I are based on recommended reference intake that are beneficial for health, whereas the cut-off value of each component in the MDS is based on the group median intake of each component. The latter scoring system may lead to bias because the MDS calculation is based on cohort- and sex-specific median values across eight food categories of the studied sample, and it may not be related to a healthy level of intake *per se* \[[@pone.0139310.ref053]\].

Our data showed that the association between both diet-quality scores and the prevalence of NAFLD was in general stronger in male than in female, and in overweight or obese subjects than in normal weight subjects. These observations were different from those reported by Koch *et al*., in which no significant interaction with age, sex, BMI, or type 2 diabetes status was detected between dietary pattern scores and liver fat measured using magnetic resonance imaging as liver signal intensity \[[@pone.0139310.ref029]\]. The gender- and BMI-specific differences in the association between diet-quality scores and the prevalence of NAFLD in our study could be largely explained by the differences in metabolic factors. Our data also suggested that the association between both diet-quality scores and the prevalence of NAFLD was not affected by the *PNPLA3* genotypes. Previous studies focusing on the interaction between the PNPLA3 genotypes and single nutrient intake, such as dietary sugar and essential omega polyunsaturated fatty acids showed that the association of these nutrients with NAFLD might be driven by a predisposing GG genotype \[[@pone.0139310.ref054],[@pone.0139310.ref055]\].

The strengths of our study include relatively large sample size, inclusion of subjects from the general population, and the use of ^1^H-MRS to assess hepatic steatosis. However, our study has several limitations. Our study was of cross-sectional in nature, thus it was not possible to examine the causal relationship between diet-quality scores and the likelihood of having NAFLD. Moreover, the FFQ captured only the short term dietary and food intakes of the subjects. Examining the relationship between diet and risk of chronic diseases using longer-term dietary and food intake data are more useful. Besides, although various common factors and major medical conditions have been adjusted in the analysis, residual potential confounding from other lifestyle factors related to the development of NAFLD, such as physical activity level might still exist \[[@pone.0139310.ref056]\],

Conclusions {#sec013}
===========

A better diet quality as characterized by a higher DQI-I and a higher consumption of vegetables, legumes and fruits was associated with a reduced likelihood of having NAFLD in Chinese adults in Hong Kong.
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BMI

:   body mass index

DBP

:   diastolic blood pressure

DM

:   diabetes mellitus

DQI-I

:   Diet Quality Index-International

FFQ

:   food frequency questionnaire

^1^H-MRS

:   proton-magnetic resonance spectroscopy

HC

:   hip circumference

IHTG

:   intrahepatic triglyceride content

MDS

:   Mediterranean Diet Score

NAFLD

:   nonalcoholic fatty liver disease

NASH

:   nonalcoholic steatohepatitis

SBP

:   systolic blood pressure

WC

:   waist circumference
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